{
    "2021-02-04": [
        [
            {
                "time": "2021-02-01",
                "original_text": "J&J submits application for its COVID-19 shot to the FDA",
                "features": {
                    "keywords": [
                        "J&J",
                        "COVID-19",
                        "FDA",
                        "submission"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-01",
                "original_text": "Johnson & Johnson Announces Submission of Application to the U.S. FDA for Emergency Use Authorization of its Investigational Single-Shot Janssen COVID-19 Vaccine Candidate",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "FDA",
                        "Emergency Use Authorization",
                        "vaccine"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-01",
                "original_text": "IBD 50 Stocks To Watch: Emergent BioSolutions, A Biotech Stock With Solid Biodefense Cred",
                "features": {
                    "keywords": [
                        "IBD 50",
                        "Emergent BioSolutions",
                        "biotech",
                        "biodefense"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-01",
                "original_text": "Doctor: 'It’s not about when I get vaccinated, it’s when we get vaccinated'",
                "features": {
                    "keywords": [
                        "vaccinated",
                        "public health",
                        "community immunity"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-01",
                "original_text": "Ortho Clinical's Public Debut Proves Disappointing",
                "features": {
                    "keywords": [
                        "Ortho Clinical",
                        "public debut",
                        "disappointing"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "medical devices"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-02-01",
                "original_text": "Johnson & Johnson Seeks Emergency Use OK for Covid Vaccine",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Covid",
                        "vaccine",
                        "Emergency Use"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-01",
                "original_text": "Novavax Surges On Highly Effective Covid Shot; Is NVAX Stock A Buy?",
                "features": {
                    "keywords": [
                        "Novavax",
                        "Covid",
                        "shot",
                        "NVAX",
                        "buy"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-01",
                "original_text": "What Biden's health care priorities should be, according to experts",
                "features": {
                    "keywords": [
                        "Biden",
                        "health care",
                        "priorities",
                        "experts"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "policy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-01",
                "original_text": "Should Investors Worry About New Coronavirus Variants?",
                "features": {
                    "keywords": [
                        "investors",
                        "coronavirus",
                        "variants",
                        "worry"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-02-01",
                "original_text": "Johnson & Johnson seeks US authorisation for Covid-19 vaccine",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "US",
                        "authorisation",
                        "Covid-19",
                        "vaccine"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}